Globus Medical (GMED) Stock Forecast & Price Target

$69.58

+0.24 (+0.35%)

(As of 09/18/2024 ET)

Globus Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 11 Analyst Ratings

Based on 11 Wall Street analysts who have issued ratings for Globus Medical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 3 have given a hold rating, and 8 have given a buy rating for GMED.

Consensus Price Target

$77.20
10.95% Upside

High Forecast	$93.00
Average Forecast	$77.20
Low Forecast	$70.00

According to the 11 analysts' twelve-month price targets for Globus Medical, the average price target is $77.20. The highest price target for GMED is $93.00, while the lowest price target for GMED is $70.00. The average price target represents a forecasted upside of 10.95% from the current price of $69.58.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$77.20	$77.00	$69.40	$68.22
Forecasted Upside	10.95% Upside	16.86% Upside	23.22% Upside	17.98% Upside

China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.

GMED Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GMED Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Globus Medical Stock vs. The Competition

Type	Globus Medical	Medical Companies	S&P 500
Consensus Rating Score	2.73	2.77	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	10.95% Upside	1,006.91% Upside	7.94% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/28/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$75.00 ➝ $77.00	+8.07%
8/8/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$85.00 ➝ $93.00	+26.00%
8/7/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$76.00 ➝ $78.00	+7.69%
8/7/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$78.00 ➝ $79.00	+14.48%
8/7/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold
8/7/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Chopra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$60.00 ➝ $78.00	+13.03%
Massive shakeup in defense contracting (Ad) There is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10. You need to check out the full story right here.
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$67.00 ➝ $71.00	-1.13%
5/20/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. O'brien Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$60.00 ➝ $80.00	+24.22%
5/8/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$64.00 ➝ $70.00	+10.41%
12/20/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$67.00 ➝ $71.00	+37.09%
10/20/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$75.00	+45.89%
2/13/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Underperform	$83.00 ➝ $63.00	+4.51%
2/10/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$90.00 ➝ $70.00	+11.16%
10/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$75.00	+25.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:12 AM ET.

GMED Forecast - Frequently Asked Questions

What is Globus Medical's forecast for 2024?: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Globus Medical is $77.20, with a high forecast of $93.00 and a low forecast of $70.00.
Should I buy or sell Globus Medical stock right now?: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GMED shares.
Does Globus Medical's stock price have much upside?: According to analysts, Globus Medical's stock has a predicted upside of 17.27% based on their 12-month stock forecasts.
Has Globus Medical been upgraded by Wall Street analysts recently?: Over the previous 90 days, Globus Medical's stock had 1 upgrade by analysts.
What analysts cover Globus Medical?: Globus Medical has been rated by research analysts at Barclays, BTIG Research, Morgan Stanley, Needham & Company LLC, Royal Bank of Canada, Truist Financial, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Globus Medical more than its competitors?: Analysts like Globus Medical less than other "medical" companies. The consensus rating score for Globus Medical is 2.73 while the average consensus rating score for "medical" companies is 2.77. Learn more on how GMED compares to other companies.